Astellas Announces FDA Approval of ASTAGRAF XL™ (tacrolimus extended ... The Herald | HeraldOnline.com ... Administration (FDA) has approved ASTAGRAF XLTM (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without ... |
